19 related articles for article (PubMed ID: 3409909)
1. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Silber S
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
[TBL] [Abstract][Full Text] [Related]
2. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
Silber S; Vogler A; Theisen K
Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
Friedensohn A; Meshulam R; Schlesinger Z
Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography.
Johnston DL; Gebhardt VA; Donald A; Kostuk WJ
Circulation; 1983 Dec; 68(6):1280-9. PubMed ID: 6315259
[TBL] [Abstract][Full Text] [Related]
5. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
Vogler AC; Silber S; Vogel M; Theisen K
Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
[TBL] [Abstract][Full Text] [Related]
6. The insufficient nitrate response: patients' characterization and response to beta and calcium blockade.
Silber S; Vogler AC; Spiegelsberger F; Vogel M; Theisen K
Eur Heart J; 1988 Jan; 9 Suppl A():125-34. PubMed ID: 3409909
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
[TBL] [Abstract][Full Text] [Related]
8. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
